Clinical trial for healthy males 18-45! Get £1,030 for your time!
Trial starts Thursday 16th February- final screening Tuesday 14th February!
Help us improve current treatments available to patients – volunteer today!
We are carrying out a clinical trial with an investigational drug which is being developed for the treatment of Malaria. The results from this clinical trial will help to work out if this drug can be developed further for testing in patients with Malaria.
This study will be carried out at our clinical trials unit at Croydon University Hospital in South London and requires an estimated time commitment of up to 6 weeks. Participation will involve one or more screening visits to determine your suitability. If you are included in the study, one in house stay of 5 days/ 4 nights and 4 out-patient/ follow up appointments. Please refer to the calendar for the proposed study dates.
Please see below for study dates:
You can take part in the study if you meet the following criteria:
- Males aged 18 to 45 (inclusive)
- Females aged 18 to 45 of non-childbearing potential. Non-childbearing potential is either (spontaneous) post-menopausal for at least 12 months or pre-menopausal with irreversible surgical sterilization for at least 6 months.
- You must weigh at least 50kg and have a Body Mass Index (BMI) within the range of 18 and 25 kg/m2(inclusive)
- You must be healthy with no relevant history of illness or ongoing medical conditions which could interfere with participation in the clinical study
- You must be a non smoker or a light smoker (5 or less cigarettes a day). Volunteers must be able to abstain from smoking while in the unit.
- You must consume less than 21 units (males), 14 units (females) of alcohol per week
- You must not have donated more than 500ml of blood within 90 days
- You must not test positive for drug or alcohol abuse, pregnancy, hepatitis B/C or HIV.
- You must not have used any medication or dietary supplements within 7 days of being given the study medication (except paracetamol)
- You must not have used any herbal supplements within 30 days of being given the study medication
- Male subjects must agree to use acceptable methods of contraception with their female partner from the time of the first administration of study medication until 100 days following administration of the last dose of study medication
Effective contraceptive methods (for partners) and a full list of medical eligibility requirements will be discussed in detail with the study doctor during screening.
In recognition of the time involved in taking part in this study, volunteers will receive £1,030 on completion of the study, provided you comply fully with all the study requirements.
Get in touch
Call our team for more information: +44 (0) 20 8664 5200 (opt 1)
We are open weekdays 9am-5pm
or email us: email@example.com
Ref: MMV_AUG 2016 (email_website_advert_text)
This advertisement has been approved by an ethics committee and any response to this advert will be recorded but you will not be under any obligation to participate in the trial.
The contents of this advert have been approved by an ethics committee. Any response to this advertisement will be recorded. Your response will not place you under any obligation to participate in this trial. You may be required to remain resident in the unit until resolution of any safety issues, after which you will be discharged from the unit.